Your browser doesn't support javascript.
loading
Evaluation of circulating plasma proteins in breast cancer using Mendelian randomisation.
Mälarstig, Anders; Grassmann, Felix; Dahl, Leo; Dimitriou, Marios; McLeod, Dianna; Gabrielson, Marike; Smith-Byrne, Karl; Thomas, Cecilia E; Huang, Tzu-Hsuan; Forsberg, Simon K G; Eriksson, Per; Ulfstedt, Mikael; Johansson, Mattias; Sokolov, Aleksandr V; Schiöth, Helgi B; Hall, Per; Schwenk, Jochen M; Czene, Kamila; Hedman, Åsa K.
Affiliation
  • Mälarstig A; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. anders.malarstig@ki.se.
  • Grassmann F; Pfizer Worldwide Research Development and Medical, Stockholm, Sweden. anders.malarstig@ki.se.
  • Dahl L; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Dimitriou M; Institute of Clinical Research and Systems Medicine, Health and Medical University, Potsdam, Germany.
  • McLeod D; Science for Life Laboratory, Department of Protein Science, KTH Royal Institute of Technology, Solna, Sweden.
  • Gabrielson M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Smith-Byrne K; Pfizer Worldwide Research Development and Medical, Stockholm, Sweden.
  • Thomas CE; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Huang TH; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Forsberg SKG; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Eriksson P; Science for Life Laboratory, Department of Protein Science, KTH Royal Institute of Technology, Solna, Sweden.
  • Ulfstedt M; Cancer Immunology Discovery, Pfizer Inc., San Diego, California, USA.
  • Johansson M; Olink Proteomics AB, Uppsala, Sweden.
  • Sokolov AV; Olink Proteomics AB, Uppsala, Sweden.
  • Schiöth HB; Olink Proteomics AB, Uppsala, Sweden.
  • Hall P; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Schwenk JM; Department of Surgical Sciences, Functional Pharmacology and Neuroscience, Uppsala University, Uppsala, Sweden.
  • Czene K; Department of Surgical Sciences, Functional Pharmacology and Neuroscience, Uppsala University, Uppsala, Sweden.
  • Hedman ÅK; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Nat Commun ; 14(1): 7680, 2023 Nov 24.
Article de En | MEDLINE | ID: mdl-37996402

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du sein Limites: Female / Humans Langue: En Journal: Nat Commun Sujet du journal: BIOLOGIA / CIENCIA Année: 2023 Type de document: Article Pays d'affiliation: Suède

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du sein Limites: Female / Humans Langue: En Journal: Nat Commun Sujet du journal: BIOLOGIA / CIENCIA Année: 2023 Type de document: Article Pays d'affiliation: Suède